Cargando…
Low dialysis potassium bath is associated with lower mortality in end-stage renal disease patients admitted to hospital with severe hyperkalemia
BACKGROUND: Hyperkalemia is a modifiable risk factor for sudden cardiac death, a leading cause of mortality in hemodialysis (HD) patients. The optimal treatment of hyperkalemia in hospitalized end-stage renal disease (ESRD) patients is nonexistent in literature, which has prompted studies from outpa...
Autores principales: | Singh, Tripti, Alagasundaramoorthy, Sayee, Gregory, Andrew, Astor, Brad C, Maursetter, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406055/ https://www.ncbi.nlm.nih.gov/pubmed/34476092 http://dx.doi.org/10.1093/ckj/sfaa263 |
Ejemplares similares
-
Hyperkalemia and Electrocardiogram Manifestations in End-Stage Renal Disease
por: Rafique, Zubaid, et al.
Publicado: (2022) -
Hypoglycemia in the treatment of hyperkalemia with insulin in patients with end-stage renal disease
por: Apel, Jill, et al.
Publicado: (2014) -
Current Management of Hyperkalemia in Patients on Dialysis
por: Bansal, Shweta, et al.
Publicado: (2020) -
Hyperkalemia in chronic peritoneal dialysis patients
por: Elliott, Andrew B., et al.
Publicado: (2022) -
Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia
por: Bushinsky, David A, et al.
Publicado: (2015)